Breast Cancer
Clinical Review
Cancer risk-reducing strategies: Focus on chemoprevention
Which patients are at risk for breast cancer, who might benefit from chemoprevention, and what therapy options are available?
Clinical Review
Cancer prevention through cascade genetic testing: A review of the current practice guidelines, barriers to testing and proposed solutions
Up to 400,000 women in the United States carry a gene mutation that translates to a high risk for breast and ovarian cancer. Cascade genetic...
From the Journals
Large analysis confirms safety of nipple-sparing mastectomy
The authors found that overall survival and breast cancer–specific survival were similar for women undergoing nipple-sparing mastectomy and those...
Latest News
IUDs may increase background enhancement on breast MRI
However, “the study findings raise the question as to whether IUD status should be documented as a matter of course prior to performing breast MRI...
Latest News
Risk for breast cancer recurrence persists past 30 years
Latest News
Many breast cancer patients use cannabis for symptom relief
Survey finds that physicians were not highly regarded as a source of information about cannabis use.
GYN Image Quiz
3D vs 2D mammography for detecting cancer in dense breasts
Question
In which categories of breast density ( FIGURE 1 ) does tomosynthesis/3D mammography increase cancer...
From the Journals
Hair follicle miniaturization common in persistent chemo-induced alopecia, case series suggests
Defined as absent or incomplete hair regrowth 6 months or more after completion of chemotherapy, pCIA has been increasingly reported in the...
Latest News
FDA issues stronger safety requirements for breast implants
This announcement comes 10 years after the FDA issued a comprehensive safety update on silicone gel–filled implants, which reported a possible...
From the Journals
Does eating nuts lead to better breast cancer outcomes?
A little may go a long way, as research to date “suggests only small amounts may be needed to gain potential benefits.”
News
New approval in early breast cancer: First advance in 20 years
Abemaciclib had already been approved for use in the treatment of HR+, HER2– advanced or metastatic breast cancer.